Expression and targeting of transcription factor ATF5 in dog gliomas
ConclusionSimilarities in expression of ATF5 in rodent, dog and human tumours, and cross species efficacy of the CP‐d/n ATF5 peptide support the development of this ATF5‐targeting approach as a novel and translational therapy in dog gliomas.
Source: Veterinary and Comparative Oncology - Category: Veterinary Research Authors: D. York, C. D. Sproul, N. Chikere, P. J. Dickinson, J. M. Angelastro Tags: ORIGINAL ARTICLE Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Neurology | Stem Cell Therapy | Stem Cells | Study | Undifferentiated Carcinoma | Veterinary Research